查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629315

栓塞治疗市场，按产品、按应用、按最终用途、按程序、按国家和地区 - 2025-2032 年全球行业分析、市场规模、市场份额和预测

Embolotherapy Market, By Product, By Application, By End Use, By Procedure, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2024 年，栓塞治疗市场规模为 41.152 亿美元，2025 年至 2032 年复合年增长率为 8.60%。

栓塞治疗市场-市场动态

由于目标患者库的扩大而增加目标手术

由于目标患者群体不断扩大，目标手术数量也随之增加，栓塞治疗设备市场在过去十年中稳步成长。 CVD是一种主要目标疾病，由于其重要性和高发病率，成功有效的治疗方法的研究一直集中在它身上。截至 2017 年，全球有超过 2 亿人患有周边血管疾病。此外，肝细胞癌和肝癌的盛行率不断增加，以及与栓塞治疗相关的高成功率和低术后併发症发生率，将在不久的将来增加对栓塞治疗设备的需求。女性第九大最常见癌症和男性第五大最常见癌症是肝癌。 2018年，全球新诊断病例超过84万例。男性发病率增加38%，女性发病率增加44%。

栓塞治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2025-2032 年）每年将以 8.60% 左右的复合年增长率成长

根据产品细分，预计栓塞剂将在 2024 年呈现最大市场份额

根据最终用途细分，医院和诊所是 2024 年的领先细分市场

根据手术细分，经导管动脉栓塞术是2024年的主导细分领域

按地区划分，北美是 2024 年的主要收入来源

栓塞治疗市场区隔分析：

全球栓塞治疗市场根据产品、应用、最终用途、程序和地区进行细分。

根据产品，市场分为栓塞弹簧圈（可推式弹簧圈、可拆卸弹簧圈）、可拆卸球囊、栓塞剂（微球、液体栓塞剂）、栓塞系统和支撑装置（微导管、导丝） 。到 2024 年，栓塞治疗市场将由栓塞剂主导。此外，由于药物洗脱微球、用于温和栓塞的校准微球以及用于原发性或继发性肝病的放射性钇90微球等药物的发展，预计该类别在预测期内将以最快的速度成长。由于微球经常用于治疗 HCC，其使用的增加直接增加了对它们的需求。美国癌症协会报告称，全球每年诊断出约 85 万例肝癌。此外，推动这一类别的另一个重要因素是对创造多用途和可生物降解微球的持续研究。透过将化疗药物与治疗性放射性核素结合，这些微球可以为 HCC 提供有效的治疗。

根据最终用途，市场分为医院和诊所、门诊手术中心（ASC）和其他。 2024年，医院和诊所类别占据主导市场。栓塞剂和栓塞治疗设备的主要最终消费者是重症监护病房、小型诊所和大型医院。在这些地区，越来越多地使用微创外科手术（例如血管、神经和泌尿外科干预措施），推动了栓塞治疗手术的数量。对于栓塞手术，拥有完善的基础设施、有利于全方位病患照护的设施（例如介入放射科）受到青睐。医院对栓塞治疗设备和栓塞剂的需求更大，因为医院的病人比门诊手术中心更多。大型医疗保健提供者不断增长的购买力以及美国和其他重要欧洲市场的栓塞治疗程序报销也推动了这一类别的扩张。

栓塞治疗市场 - 地理洞察

2024年，北美因其高度发展和先进的医疗基础设施而占据最大的栓塞治疗市场份额，其中包括拥有最新栓塞治疗技术的专科中心、介入放射科和最先进的医疗设施。特别是在美国，医疗保健支出是世界上最高的。除了促进尖端技术的采用外，对医疗保健资源的大量投资也使栓塞疗法等现代医疗程序更加普及。北美的医疗保健人员素质高、经验丰富，包括专业护理人员和介入放射科医生。栓塞治疗的有效实施和发展取决于技术人员的可用性。该地区也处于技术进步和医学研究的前沿。

预计亚太地区将占据相当大的市场份额。在亚太国家，癌症、週边血管疾病和神经系统疾病等慢性疾病呈现上升趋势。由于这些情况非常适合栓塞手术，因此该地区对栓塞工具和程序的需求不断增加。在亚太地区，政府和私人医疗保健提供者正在加大对最先进医疗技术和医疗保健基础设施的投资。全球所有新癌症病例中 50% 发生在亚太地区，到 2030 年，亚洲癌症相关死亡人数预计将增加 36%。世界经济论坛预计，到 2024 年，全球 58% 的子宫颈癌死亡和 45% 的乳癌诊断发生在亚洲。因此，预计上述因素将保持该地区的领先地位。

栓塞治疗市场-竞争格局：

栓塞治疗市场的主要参与者包括Terumo Corporation、Merit Medical Systems, Inc.、Simbionix USA Corporation、Cook、Boston Scientific Corporation、Penumbra, Inc.、Meril Life Sciences Pvt.。有限公司、美敦力等。市场上的公司一直专注于创新。提供更有效的解决方案来回应不断变化的最终用户需求是一个主要焦点。由于参与者众多，栓塞治疗市场被认为相当分散。此外，产业参与者已将合作伙伴关係作为扩大产品范围和地理影响力的重要策略。例如，2023 年 12 月，Terumo Medical Corporation 的创新 AZUR HydroPack 外围线圈系统在美国推出。 AZUR HydroPack 线圈系统采用铂金和水凝胶线圈，具有灵活的通用形状，用于定位和填充容器内的空间。

近期发展

2024 年 6 月：波士顿科学公司宣布计画收购总部位于硅谷的医疗器材公司 Silk Road Medical Inc.。透过一种称为经颈动脉血管重建的微创治疗，后者提供了帮助颈动脉疾病患者避免中风的产品。

2024 年 2 月：法国领先的医学影像人工智慧专家 AI 宣布建立策略合作伙伴关係，将其获得 CE 标誌的 CINA-iPE 解决方案整合到 Blackford AI 平台中。此次合作为医疗专业人员提供了最先进的资源，可以在标准 CT 扫描过程中更准确地检测偶发性肺栓塞。

2023 年 9 月：瑞典 CDMO 和可降解淀粉微球供应商 Magle Group 与 Sirtex Medical 宣布达成独家全球分销协议。作为合作的一部分，Sirtex Medical 在新市场和现有市场独家经销 Magle Group 的 EmboCept S DSM 50 μm 化疗栓塞产品。

目录

第一章：栓塞治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品分類的栓塞疗法市场片段
    • 按应用分類的栓塞治疗市场片段
    • 以最终用途分類的栓塞治疗市场片段
    • 按程序分類的栓塞治疗市场片段
    • 按国家/地区分類的栓塞治疗市场片段
    • 按地区分類的栓塞治疗市场片段
  • 竞争洞察

第 3 章：栓塞疗法主要市场趋势

  • 栓塞治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 栓塞治疗市场限制
    • 市场限制影响分析
  • 栓塞治疗市场机会
  • 栓塞治疗市场未来趋势

第 4 章：栓塞疗法产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：栓塞治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：栓塞治疗市场格局

  • 2024 年栓塞治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：栓塞治疗市场 - 副产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 栓塞线圈
      • 可推线圈
      • 可拆卸线圈
    • 可拆卸气球
    • 栓塞剂
      • 微球
      • 液态栓塞剂
    • 栓塞系统
    • 支援设备
      • 微导管
      • 导丝

第 8 章：栓塞治疗市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 肿瘤学
      • 肺癌
      • 肾癌
      • 肝癌
      • 乳癌
      • 其他癌症
    • 周围血管疾病
    • 泌尿外科和肾臟病学
      • 子宫肌瘤
      • 良性摄护腺增生
      • 其他泌尿科和肾臟科应用
    • 神经病学
      • 脑动静脉畸形
      • 脑动脉瘤
    • 胃肠道疾病

第 9 章：栓塞治疗市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院和诊所
    • 门诊手术中心 (ASC)
    • 其他的

第 10 章：栓塞治疗市场 - 按程序

  • 概述
    • 按程序分類的细分市场占有率分析
    • 经导管动脉栓塞术
    • 经动脉化疗栓塞术
    • 经导管动脉放射栓塞/选择性内放射治疗

第 11 章：栓塞治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美栓塞疗法主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用途）
    • 北美市场规模和预测（按程序）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲栓塞疗法主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按产品）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用途）
    • 欧洲市场规模和预测（按程序）
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区栓塞疗法主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用途）
    • 亚太地区市场规模与预测（按程序）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲栓塞疗法主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 拉丁美洲市场规模与预测（按程序）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲栓塞疗法主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用途）
    • 中东和非洲市场规模及预测（按程序）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 栓塞治疗产业

  • 竞争仪表板
  • 公司简介
    • Terumo Corporation
    • Merit Medical Systems, Inc.
    • Simbionix USA Corporation
    • Cook
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Medtronic
    • BTG International Limited
    • ABK Biomedical
    • Abbott
    • AngioDynamics
    • IMBIOTECHNOLOGIES LTD.
    • Debakey Medlife Private Limited
    • Heraeus Holding
    • Guerbet
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • BD
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4488

REPORT HIGHLIGHT

Embolotherapy Market size was valued at US$ 4,115.2 Million in 2024, expanding at a CAGR of 8.60% from 2025 to 2032.

Embolotherapy is the practice of treating or halting uncontrollable bleeding by blocking arteries with a device (such as a balloon catheter). By using this method, bleeding is managed, and tumours are decreased. By limiting abnormal blood vessels, this endovascular technique aims to halt bleeding. Postpartum conditions, pelvic tract bleeding, and cervical uprooted pregnancy are the main conditions treated with embolotherapy. Lesions to the liver, spleen, and kidneys are among the vascular, non-operative, and iatrogenic solid organ damage that this treatment has demonstrated potential to treat. Embolotherapy is used to remove duodenal varices, revascularize tissues and organs before surgery, and treat enlarged uterine fibroids. Selecting an embolization agent with the required degree of vascular blockage persistence is therefore required. The need for embolotherapy will expand due to the growing prevalence of liver and hepatic cancers, as well as the top manufacturers' heightened focus on technological advancements. Additionally, increased infrastructure construction expenses and better research & development skills to promote healthcare technology will drive growth in the embolotherapy market. Growing patient demand for minimally invasive procedures and increased personal disposable income are other factors driving market expansion.

Embolotherapy Market- Market Dynamics

Increase in target procedures due to the expanding target patient pool

The market for embolotherapy devices has grown steadily over the past ten years as a result of an increase in target procedures due to the expanding target patient pool. CVD is a major target illness, and because of its significance and high incidence, research on successful and efficient treatments has focused on it. Globally, more than 200 million people had peripheral vascular disorders as of 2017. The same source claims that the prevalence of these illnesses increases with age, with a prevalence rate of more than 20% seen in the over-80 age range. Moreover, The increasing prevalence of hepatocellular and liver cancers, along with the high success rate and low rate of post-operative complications linked to embolotherapy treatments, will increase the need for embolotherapy devices in the near future. The ninth most prevalent cancer in women and the fifth most common in men is liver cancer. More than 840,000 new cases were diagnosed worldwide in 2018. In addition, the UK had a 42% increase in kidney cancer incidence rates during the previous ten years. There was a 38% incidence rate in males and a 44% increase rate in females.

Embolotherapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.60% over the forecast period (2025-2032)

Based on product segmentation, the embolic agents were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals and clinics were the leading segment in 2024

Based on procedure segmentation, Transcatheter Arterial Embolization was the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Embolotherapy Market- Segmentation Analysis:

The Global Embolotherapy Market is segmented on the basis of Product, Application, End Use, Procedure, and Region.

On the basis of product, the market is segregated into Embolization Coil (Pushable Coils, Detachable Coils), Detachable Balloons, Embolic Agents (Microspheres, Liquid Embolic Agents), Embolic Plug Systems, and Support Devices (Microcatheters, Guidewires). The market for embolotherapy is dominated by embolic agents in 2024. For the most part, this segment dominates the market because of the growing usage of embolic agents in several interventional radiological treatments. Additionally, the category is anticipated to grow at the fastest rate during the forecast period due to the developments in such agents, such as drug-eluting microspheres, calibrated microspheres for bland embolization, and radioactive yttrium-90 microspheres for primary or secondary liver diseases. Since microspheres are frequently employed to treat HCC, their increasing use directly contributes to the demand for them. The American Cancer Society reports that about 850,000 liver cancer diagnoses are made worldwide each year. Moreover, another important factor propelling this category is the continuous study of creating multipurpose and biodegradable microspheres. By combining chemotherapeutic drugs with therapeutic radionuclides, these microspheres can provide an efficient treatment for HCC.

Based on end use, the market is divided into Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), and Others. In 2024, the hospitals and clinics category held a dominant market share. The primary end consumers of embolic agents and embolotherapy equipment are critical care units, minor clinics, and large hospitals. At these locations, the number of embolotherapy procedures is being driven by the growing use of minimally invasive surgical procedures, such as vascular, neurological, and urological interventions. For embolization operations, facilities with established infrastructure that facilitates all-encompassing patient care-such as interventional radiology departments-are favoured. There is a greater need for embolotherapy equipment and embolic agents in hospitals because they have more patients than ambulatory surgery centres. The expansion of this category is also fueled by the larger healthcare providers' growing purchasing power and the availability of reimbursement for embolotherapy procedures in the United States and other significant European markets.

Embolotherapy Market- Geographical Insights

In 2024, North America held the largest market share for embolotherapy because of its highly developed and advanced healthcare infrastructure, which includes specialist centres with the newest embolotherapy technology, interventional radiology departments, and state-of-the-art medical facilities. Particularly in the United States, healthcare spending is among the highest in the world. In addition to facilitating the adoption of cutting-edge technologies, the substantial investment in healthcare resources makes modern medical procedures, such as embolotherapy, widely accessible. The healthcare workforce in North America is highly qualified and experienced and includes specialized nursing personnel and interventional radiologists. The effective implementation and growth of embolotherapy treatments depend on the availability of skilled personnel. The area is also at the forefront of technical advancement and medical research.

The Asia-Pacific region is anticipated to account for a sizeable portion of the market. In Asia-Pacific nations, chronic illnesses like cancer, peripheral vascular disease, and neurological disorders are on the rise. The region's need for embolization tools and procedures is rising as a result of these situations being perfect candidates for embolization operations. In Asia Pacific, governments and private healthcare providers are investing more in state-of-the-art medical technology and healthcare infrastructure. 50% of all new cancer cases worldwide occur in Asia Pacific, and by 2030, the number of cancer-related fatalities in Asia is predicted to rise by 36%. In 2024, the World Economic Forum anticipated that 58% of cervical cancer fatalities and 45% of all breast cancer diagnoses globally occur in Asia. Therefore, it is anticipated that the elements above will maintain the region's leading position.

Embolotherapy Market- Competitive Landscape:

Key players in the embolotherapy market include Terumo Corporation, Merit Medical Systems, Inc., Simbionix USA Corporation, Cook, Boston Scientific Corporation, Penumbra, Inc., Meril Life Sciences Pvt. Ltd., Medtronic, and others. The market's companies have been concentrating on innovations. Offering more effective solutions in response to changing end-user needs is a major focus. The market for embolotherapy is thought to be fairly fragmented because of the large number of players. In addition, industry participants have made partnerships a crucial tactic in their efforts to broaden both their product offerings and their geographical presence. For instance, in December 2023, the innovative AZUR HydroPack Peripheral Coil System from Terumo Medical Corporation was introduced in the US. A platinum and hydrogel coil with a flexible, universal shape, the AZUR HydroPack Coil System is made to locate and fill space inside the vessel.

Recent Development

June 2024: Boston Scientific Corporation announced plans to buy Silk Road Medical Inc., a medical device firm based in Silicon Valley. Through a minimally invasive treatment called trans carotid artery revascularization, the latter provides products to help patients with carotid artery disease avoid strokes.

February 2024: Leading French medical imaging AI specialist AI announced a strategic partnership to integrate its CE-marked CINA-iPE solution into the Blackford AI Platform. This collaboration gives medical professionals cutting-edge resources to detect incidental pulmonary embolisms during standard CT scans more accurately.

September 2023: Magle Group, a Swedish CDMO and vendor of degradable starch microspheres, and Sirtex Medical announced an exclusive global distribution deal. Sirtex Medical exclusively distributes the EmboCept S DSM 50 μm chemoembolization product from Magle Group in both new and existing markets as part of the collaboration.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EMBOLOTHERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Simbionix USA Corporation
  • Cook
  • Boston Scientific Corporation
  • Penumbra, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Medtronic
  • BTG International Limited
  • ABK Biomedical
  • Abbott
  • AngioDynamics
  • IMBIOTECHNOLOGIES LTD.
  • Debakey Medlife Private Limited
  • Heraeus Holding
  • Guerbet
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • BD
  • Others

GLOBAL EMBOLOTHERAPY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Embolization Coil
  • Pushable Coils
  • Detachable Coils
  • Detachable Balloons
  • Embolic Agents
  • Microspheres
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Support Devices
  • Microcatheters
  • Guidewires

GLOBAL EMBOLOTHERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Lung Cancer
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Urology and Nephrology
  • Uterine Fibroids
  • Benign Prostatic Hyperplasia
  • Other Urology and Nephrology Applications
  • Neurology
  • Cerebral Arteriovenous Malformations
  • Brain Aneurysm
  • GIT Disorders

GLOBAL EMBOLOTHERAPY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

GLOBAL EMBOLOTHERAPY MARKET, BY PROCEDURE- MARKET ANALYSIS, 2019 - 2032

  • Transcatheter Arterial Embolization
  • Transarterial Chemoembolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

GLOBAL EMBOLOTHERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Embolotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Embolotherapy Market Snippet by Product
    • 2.1.2. Embolotherapy Market Snippet by Application
    • 2.1.3. Embolotherapy Market Snippet by End Use
    • 2.1.4. Embolotherapy Market Snippet by Procedure
    • 2.1.5. Embolotherapy Market Snippet by Country
    • 2.1.6. Embolotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Embolotherapy Key Market Trends

  • 3.1. Embolotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Embolotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Embolotherapy Market Opportunities
  • 3.4. Embolotherapy Market Future Trends

4. Embolotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Embolotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Embolotherapy Market Landscape

  • 6.1. Embolotherapy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Embolotherapy Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Embolization Coil
      • 7.1.2.1. Pushable Coils
      • 7.1.2.2. Detachable Coils
    • 7.1.3. Detachable Balloons
    • 7.1.4. Embolic Agents
      • 7.1.4.1. Microspheres
      • 7.1.4.2. Liquid Embolic Agents
    • 7.1.5. Embolic Plug Systems
    • 7.1.6. Support Devices
      • 7.1.6.1. Microcatheters
      • 7.1.6.2. Guidewires

8. Embolotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Oncology
      • 8.1.2.1. Lung Cancer
      • 8.1.2.2. Kidney Cancer
      • 8.1.2.3. Liver Cancer
      • 8.1.2.4. Breast Cancer
      • 8.1.2.5. Other Cancers
    • 8.1.3. Peripheral Vascular Diseases
    • 8.1.4. Urology and Nephrology
      • 8.1.4.1. Uterine Fibroids
      • 8.1.4.2. Benign Prostatic Hyperplasia
      • 8.1.4.3. Other Urology and Nephrology Applications
    • 8.1.5. Neurology
      • 8.1.5.1. Cerebral Arteriovenous Malformations
      • 8.1.5.2. Brain Aneurysm
    • 8.1.6. GIT Disorders

9. Embolotherapy Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Others

10. Embolotherapy Market - By Procedure

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 10.1.2. Transcatheter Arterial Embolization
    • 10.1.3. Transarterial Chemoembolization
    • 10.1.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

11. Embolotherapy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Embolotherapy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Embolotherapy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.9. France
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.9.6. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.10. Italy
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.10.6. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.11. Spain
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.12. United Kingdom
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.12.6. United Kingdom Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.13. Russia
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.14. Netherlands
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.15. Sweden
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Embolotherapy Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.10. South Korea
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.10.6. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.11. Japan
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.11.6. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Embolotherapy Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Embolotherapy Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Embolotherapy Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Terumo Corporation
    • 12.2.2. Merit Medical Systems, Inc.
    • 12.2.3. Simbionix USA Corporation
    • 12.2.4. Cook
    • 12.2.5. Boston Scientific Corporation
    • 12.2.6. Penumbra, Inc.
    • 12.2.7. Meril Life Sciences Pvt. Ltd.
    • 12.2.8. Medtronic
    • 12.2.9. BTG International Limited
    • 12.2.10. ABK Biomedical
    • 12.2.11. Abbott
    • 12.2.12. AngioDynamics
    • 12.2.13. IMBIOTECHNOLOGIES LTD.
    • 12.2.14. Debakey Medlife Private Limited
    • 12.2.15. Heraeus Holding
    • 12.2.16. Guerbet
    • 12.2.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 12.2.18. BD
    • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us